IMVT - Immunovant  - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

IMVT is currently covered by 7 analysts with an average price target of $31.42. This is a potential upside of $14.07 (81.1%) from yesterday's end of day stock price of $17.35.

Immunovant 's activity chart (see below) currently has 144 price targets and 113 ratings on display. The stock rating distribution of IMVT is 93.75% BUY and 6.25% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 60.2% with an average time for these price targets to be met of 179.17 days.

Highest price target for IMVT is $61, Lowest price target is $17, average price target is $36.83.

Most recent stock forecast was given by BRIAN CHENG from JPMORGAN on 29-Sep-2025. First documented stock forecast 06-Jan-2020.

Currently out of the existing stock ratings of IMVT, 15 are a BUY (93.75%), 1 are a HOLD (6.25%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$33

$15.97 (93.78%)

$37

14 days ago
(29-Sep-2025)

0/4 (0%)

$16.88 (104.71%)

Buy

$35

$17.97 (105.52%)

$51

1 months 10 days ago
(03-Sep-2025)

11/21 (52.38%)

$18.88 (117.12%)

268

Buy

$30

$12.97 (76.16%)

$33

2 months 2 days ago
(11-Aug-2025)

1/4 (25%)

$14.79 (97.24%)

126

Hold

$17

$-0.03 (-0.18%)

$41

5 months 22 days ago
(21-Apr-2025)

2/6 (33.33%)

$2.75 (19.30%)

41

Buy

$61

$43.97 (258.19%)

$52

6 months 24 days ago
(19-Mar-2025)

2/4 (50%)

$41.31 (209.80%)

125

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is IMVT (Immunovant ) average time for price targets to be met?

On average it took 179.17 days on average for the stock forecasts to be realized with a an average price target met ratio 60.2

Which analyst has the current highest performing score on IMVT (Immunovant ) with a proven track record?

GBOLA AMUSA

Which analyst has the most public recommendations on IMVT (Immunovant )?

Gbola Amusa works at CHARDAN CAPITAL and has 0 price targets and 7 ratings on IMVT

Which analyst is the currently most bullish on IMVT (Immunovant )?

Alex Thompson with highest potential upside - $43.97

Which analyst is the currently most reserved on IMVT (Immunovant )?

Tiago Fauth with lowest potential downside - -$10.03

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?